Redefining Bioefficacy: Nano-EnhancedCranberry Extract for Next-Gen Formulations
In response to chronic bioavailabilitychallenges in botanical applications, Blue Eyes Biotech unveils itspatent-pending Water-Soluble Cranberry Extract – clinically proven to achieve75% higher plasma concentration versus conventional juice powders within 2hours post-administration (Human Pharmacokinetics Study, n=45). Thisbreakthrough addresses critical limitations in nutraceutical gummies,effervescent tablets, and IV-compatible nutraceuticals where solubility dictatesefficacy.
Core Technology Advantages
Our proprietary nano-micellar encapsulationsystem (Patent No. WO2024/XXXXXX) enables:
- True cold-water solubility (0.5% w/v @4°C) without surfactants
- 82.3% anthocyanin retention vs. 43% inspray-dried powders (HPLC-UV validation)
- pH stability (2.0-9.0) for acidicbeverages to alkaline protein shakes
- 45% reduced dosage requirements forequivalent therapeutic effects
Validation & Safety Transparency
Third-party OECD 427 acute toxicity studiesconfirm Class 5 safety (LD₅₀ >2000mg/kg).Each batch includes:
- Full SDS documentation with heavy metal(Pb<0.1ppm), pesticide (EU MRL compliant), and solvent residue profiles
- Bioavailability comparison charts vs.juice powder, spray-dried, and freeze-dried benchmarks
- Accelerated stability data (24 months @25°C/60% RH)
Application-Specific Benefits
1. Pharmaceuticals: Ideal for IVnutraceuticals (lyophilized vials) and sublingual strips
2. Functional Foods: Enablesclear-formulation beverages without sedimentation
3. Cosmeceuticals: Enhances transdermaldelivery in serums by 3.2x (Franz cell assay)
Supply Chain Readiness
- Available in GMP-compliant batches from5kg R&D samples to 500kg drums
- Documentation suite: SDS, Certificate ofAnalysis (CoA), DMF Type IV filings
- Customizable: Anthocyanin (25-40%), PACs(≥36%), ororganic acid profiles
Request Technical Dossier
Formulators seeking clinically-backedsolubility solutions can:
① DownloadImmediate SDS Access: www.blueeyes-bio.com
② RequestComparative Bioavailability Report: [email protected]